Bartosz Wasąg

4.5k total citations
93 papers, 2.7k citations indexed

About

Bartosz Wasąg is a scholar working on Surgery, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Bartosz Wasąg has authored 93 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Surgery, 23 papers in Molecular Biology and 21 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Bartosz Wasąg's work include Lipoproteins and Cardiovascular Health (15 papers), Gastrointestinal Tumor Research and Treatment (14 papers) and Sarcoma Diagnosis and Treatment (8 papers). Bartosz Wasąg is often cited by papers focused on Lipoproteins and Cardiovascular Health (15 papers), Gastrointestinal Tumor Research and Treatment (14 papers) and Sarcoma Diagnosis and Treatment (8 papers). Bartosz Wasąg collaborates with scholars based in Poland, Belgium and United States. Bartosz Wasąg's co-authors include Raf Sciot, Maria Dêbiec‐Rychter, Michel Stul, Anne Hagemeijer, A. van Oosterom, Janusz Limon, Jerzy Lasota, Herlinde Dumez, Jacek Jasiecki and Jan Cools and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Gastroenterology.

In The Last Decade

Bartosz Wasąg

90 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bartosz Wasąg Poland 28 1.4k 1.2k 736 465 399 93 2.7k
Yingyong Hou China 28 1.0k 0.7× 331 0.3× 787 1.1× 1.1k 2.3× 1.1k 2.6× 233 2.9k
Hans-Juergen Schulten Saudi Arabia 28 457 0.3× 326 0.3× 354 0.5× 764 1.6× 354 0.9× 91 1.9k
Toshio Imada Japan 27 1.1k 0.8× 361 0.3× 1000 1.4× 476 1.0× 679 1.7× 202 2.8k
Kazuyuki Ishida Japan 33 795 0.6× 122 0.1× 1.1k 1.5× 799 1.7× 1.1k 2.6× 190 3.4k
Koichi Miwa Japan 30 1.3k 0.9× 787 0.6× 1.8k 2.4× 570 1.2× 969 2.4× 124 3.4k
Chunhua Yu United States 24 1.3k 0.9× 406 0.3× 1.1k 1.5× 1.3k 2.7× 319 0.8× 45 3.1k
Charles S. Harmon United States 22 735 0.5× 288 0.2× 174 0.2× 768 1.7× 422 1.1× 50 2.1k
Kazuya Kuraoka Japan 22 392 0.3× 123 0.1× 616 0.8× 880 1.9× 726 1.8× 113 2.1k
Hongwei Zhang China 27 847 0.6× 297 0.2× 701 1.0× 895 1.9× 606 1.5× 103 2.3k
In‐Gu Do South Korea 31 691 0.5× 125 0.1× 377 0.5× 1.1k 2.3× 1.0k 2.6× 97 2.5k

Countries citing papers authored by Bartosz Wasąg

Since Specialization
Citations

This map shows the geographic impact of Bartosz Wasąg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bartosz Wasąg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bartosz Wasąg more than expected).

Fields of papers citing papers by Bartosz Wasąg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bartosz Wasąg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bartosz Wasąg. The network helps show where Bartosz Wasąg may publish in the future.

Co-authorship network of co-authors of Bartosz Wasąg

This figure shows the co-authorship network connecting the top 25 collaborators of Bartosz Wasąg. A scholar is included among the top collaborators of Bartosz Wasąg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bartosz Wasąg. Bartosz Wasąg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Janaszak‐Jasiecka, Anna, Magdalena Chmara, Leszek Kalinowski, et al.. (2025). Characterization of selected LDLR substitutions in patients with familial hypercholesterolemia. PubMed. 62. 30–37.
2.
Myśliwiec, Małgorzata, Mieczysław Walczak, Jarosław Peregud‐Pogorzelski, et al.. (2024). 2024 Polish Recommendations for the Management of Familial Hypercholesterolemia in Children and Adolescents.. Archives of Medical Science. 20(6). 1741–1753. 1 indexed citations
3.
Jasiecki, Jacek, Anna Janaszak‐Jasiecka, Magdalena Chmara, et al.. (2023). Novel Tools for Comprehensive Functional Analysis of LDLR (Low-Density Lipoprotein Receptor) Variants. International Journal of Molecular Sciences. 24(14). 11435–11435. 4 indexed citations
4.
Wasąg, Bartosz, et al.. (2023). Diagnosis and treatment of patients with breast cancer and mutation in the BRCA1/2 genes. Oncology in Clinical Practice. 20(3). 222–228. 1 indexed citations
5.
Wasąg, Bartosz, et al.. (2023). The molecular profile in patients with polycythemia vera and essential thrombocythemia is dynamic and correlates with disease’s phenotype. Frontiers in Oncology. 13. 1224590–1224590. 1 indexed citations
6.
Koczkowska, Magdalena, Maciej Stukan, Dariusz Wydra, et al.. (2023). Analysis of BRCA1 and BRCA2 alternative splicing in predisposition to ovarian cancer. Experimental and Molecular Pathology. 130. 104856–104856. 3 indexed citations
7.
Markiet, Karolina, et al.. (2022). Synchronous bilateral multifocal basal cell adenomas of the parotid gland—a case report. BMC Oral Health. 22(1). 314–314. 1 indexed citations
8.
Kozak, Katarzyna, Artur Kowalik, Bartosz Wasąg, et al.. (2020). Cell-free DNA BRAF V600E measurements during BRAF inhibitor therapy of metastatic melanoma: long-term analysis. Tumori Journal. 106(3). 241–248. 14 indexed citations
9.
Dziadziuszko, Rafał, Egbert F. Smit, Urania Dafni, et al.. (2019). Afatinib in NSCLC With HER2 Mutations: Results of the Prospective, Open-Label Phase II NICHE Trial of European Thoracic Oncology Platform (ETOP). Journal of Thoracic Oncology. 14(6). 1086–1094. 107 indexed citations
10.
Wierzba, Jolanta, et al.. (2019). Genetic Mosaicism in a Group of Patients With Cornelia de Lange Syndrome. Frontiers in Pediatrics. 7. 203–203. 11 indexed citations
11.
Brożek, Izabela, Magdalena Ratajska, Magdalena Koczkowska, et al.. (2018). ovarian cancer in a family with coexistence of germline nf1 and brca1 mutations case report. 1 indexed citations
12.
Gilis‐Malinowska, Natasza, Rafał Gałąska, Grzegorz Raczak, et al.. (2018). Long-term lipoprotein apheresis in the treatment of severe familial hypercholesterolemia refractory to high intensity statin therapy: Three year experience at a lipoprotein apheresis centre. Cardiology Journal. 26(6). 669–679. 12 indexed citations
13.
Wasąg, Bartosz, Agnieszka Woźniak, Joanna Pikiel, et al.. (2017). Influence of Cytochrome P450, ABC and SLC Gene Polymorphisms on Imatinib Therapy Outcome of Patients with Gastrointestinal Stromal Tumours (GIST). Folia Biologica. 63(2). 78–83. 3 indexed citations
14.
Górska, Aleksandra, Marek Niedoszytko, Agnieszka Maciejewska, et al.. (2016). The Role of TRAF4 and B3GAT1 Gene Expression in the Food Hypersensitivity and Insect Venom Allergy in Mastocytosis. Archivum Immunologiae et Therapiae Experimentalis. 64(6). 497–503. 13 indexed citations
15.
16.
Beel, Andrew J., Bartosz Wasąg, Jan Cools, et al.. (2008). Flow cytometric analysis of oncogenic signal transduction pathways in primary leukaemic cells. Haematologica. 93. 223–224. 1 indexed citations
17.
Dêbiec‐Rychter, Maria, Jan Cools, Herlinde Dumez, et al.. (2005). Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants. Gastroenterology. 128(2). 270–279. 396 indexed citations
18.
Lasota, Jerzy, Agnieszka Woźniak, Janusz Kopczyński, et al.. (2004). Loss of heterozygosity on chromosome 22q in gastrointestinal stromal tumors (GISTs): a study on 50 cases. Laboratory Investigation. 85(2). 237–247. 33 indexed citations
19.
Gruchała, Marcin, Dariusz Ciećwierz, Bartosz Wasąg, et al.. (2002). The Scal atrial natriuretic peptide gene polymorphism in relation to nonfatal myocardial infarction in patients with angiographically confirmed coronary heart disease. Journal of the American College of Cardiology. 39. 283–283. 3 indexed citations
20.
Bellwon, Jerzy, Marcin Gruchała, Janusz Siebert, et al.. (1999). Scal Polymorphism of the Atrial Natriuretic Peptide Gene and Blood Preassure in Subjects without Clinical Manifestations of Atherosclerotic Disease. Arterial Hypertension. 3(4). 227–232. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yingyong Hou Breakdown of academic impact, for papers by Hans-Juergen Schulten Breakdown of academic impact, for papers by Toshio Imada Breakdown of academic impact, for papers by Kazuyuki Ishida Breakdown of academic impact, for papers by Koichi Miwa Breakdown of academic impact, for papers by Chunhua Yu Breakdown of academic impact, for papers by Charles S. Harmon Breakdown of academic impact, for papers by Kazuya Kuraoka Breakdown of academic impact, for papers by Hongwei Zhang Breakdown of academic impact, for papers by In‐Gu Do
Rankless by CCL
2026